Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma.
Fibroblast growth factor receptor 4 (FGFR4) polymorphisms are positively correlated with tumor progression in numerous malignant tumors. However, the association between FGFR4 genetic variants and the risk of hepatocellular carcinoma (HCC) has not yet been determined. In this study, we investigated...
Main Authors: | Ming-Jen Sheu, Ming-Ju Hsieh, Whei-Ling Chiang, Shun-Fa Yang, Hsiang-Lin Lee, Liang-Ming Lee, Chao-Bin Yeh |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4393280?pdf=render |
Similar Items
-
The Clinical Significance of the Insulin-Like Growth Factor-1 Receptor Polymorphism in Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation
by: Tu-Chen Liu, et al.
Published: (2016-05-01) -
Hepatocarcinoma
by: Iván Nieto, et al.
Published: (2007-12-01) -
Gene polymorphisms of inflammatory factors in liver cirrhosis
by: Sailan Xiao, et al.
Published: (2023-04-01) -
Multi-Omics Analyses Identify Signatures in Patients with Liver Cirrhosis and Hepatocellular Carcinoma
by: Ming-Wei Lai, et al.
Published: (2022-12-01) -
Hepatocarcinoma invadiendo estómago
by: A. Guzmán-Lepe, et al.
Published: (2021-01-01)